Vertex announces further expansion in the boston seaport at dedication of the jeffrey leiden center for cell and genetic therapies

Boston--(business wire)--at a dedication today of the new jeffrey leiden center for cell and genetic therapies in boston's seaport, vertex pharmaceuticals incorporated (nasdaq: vrtx) announced plans to build another 344,000 square foot facility in the seaport to support the company's continued rapid growth, in particular the expansion of its cell and genetic therapies programs. with the completion of this new site expected in 2025, vertex will occupy 1.9 million square feet of real estate in th
VRTX Ratings Summary
VRTX Quant Ranking